Prevalence

An estimate of the number of people in Italy living after a childhood cancer
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
Cancer cost profiles: The Epicost estimation approach
Cancer prevalence by phase of care: an indicator for assessing health service needs
Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020
Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries
Embryonal cancers in Europe
Epidemiology of glial and non-glial brain tumours in Europe
Epidemiology of rare cancers and inequalities in oncologic outcomes
Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes
Incidence and survival of rare urogenital cancers in Europe
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002
Italian cancer figures - Report 2015: The burden of rare cancers in Italy
Italy 2015: 3 million Italians are living after a cancer diagnosis, both incidence and mortality are decreasing
Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project
Rare cancers are not so rare: the rare cancer burden in Europe
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting
Rare thoracic cancers, including peritoneum mesothelioma
Stime di prevalenza in italia della popolazione adulta con diagnosi di tumore in età infantile
The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project

This website uses cookies to ensure you get the best experience. Learn more about it.